Table 4.
Spearman correlation analysis to evaluate the correlation between final BCVA and other variables in PM-CNV patients after treatment.
| Characteristics | Spearman correlation analysis | |
|---|---|---|
| Rs | P | |
| Baseline BCVA | 0.681 | <0.001 |
| OCT at baseline | ||
| HRF height | 0.577 | <0.001 |
| Intraretinal or subretinal fluid | −0.072 | 0.625 |
| EZ Disrupted/Absent | 0.368 | 0.01 |
| RPE Disrupted/Absent | 0.194 | 0.186 |
| OCTA at baseline | ||
| CNV area | 0.242 | 0.097 |
| OCT after treatment | ||
| HRF height | 0.498 | <0.001 |
| EZ Disrupted/Absent | 0.454 | 0.001 |
| RPE Disrupted/Absent | 0.437 | 0.002 |
| OCTA after treatment | ||
| CNV area | 0.212 | 0.148 |
PM, pathologic myopia; CNV, choroidal neovascularization; BCVA, best corrected visual acuity; LogMAR, logarithm of the minimum angle of resolution; HRF, hyperreflective foci; EZ, ellipsoid zone; RPE, retinal pigment epithelium; P with statistical significance is shown in boldface.